It was determined that the expression of GSDMB, which could be upregulated by interferon and mediated by pyroptosis in target cells (Zhou et al., 2020), was related to the response to HER2-targeted therapy and prognosis in breast cancer (Molina-Crespo et al., 2019). Here, ERBB2 is linked to breast cancer.